Emotion Regulation Group Study (EmoReg)

February 8, 2023 updated by: Camille Nemitz Piguet

Emotion Regulation Group Intervention for Late Adolescents: a Clinical Trial

A clinical trial to evaluate the effects of an eight-week emotion regulation group intervention designed for adolescents (16-20 years old) on the levels of emotion dysregulation both self-reported by the adolescent and reported by his/her parent/caregiver (pre-post comparison). The long-term effect will also be measured at a third-time point, three months after the end of the intervention. The intervention will consist of 90-minute sessions once a week for 8 weeks, in groups of eight participants. The intervention proposed for this study is an adaptation from different interventions already in use for adolescents in clinical practice, such as Dialectical Behavior Therapy (DBT), Mentalization-Based Treatment (MBT) and Mindfulness-Based Intervention (MBI).

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 16 to 20 years old.
  • > 4 criteria of borderline symptoms (out of the 9 listed in the DSM-5) including emotional liability
  • French speaking
  • Availability during the whole study
  • Willingness in participating to the intervention and the research
  • Informed consent read and signed

Exclusion Criteria:

  • Current hospitalization
  • Psychotic disorder
  • Severe and persistent substance addiction
  • Antisocial personality disorder
  • Inability to participate in group sessions
  • Current pregnancy
  • Non-French speaking
  • Previous enrolment into the current study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: psychotherapeutic intervention with class risk A (low risk, no invasive procedure)
an eight-week emotion regulation group intervention
90 minute sessions once a week for 8 weeks, in groups of eight participants. DBT, MBT and MBI inspired, psychoeducative intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from Baseline in Difficulties in emotion regulation scale (DERS)
Time Frame: V2 (within two weeks after the end of the intervention)
36 items self-report scale: Higher scores suggest greater problems with emotion regulation.
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Difficulties in emotion regulation scale (DERS)
Time Frame: V3 (3 months after the intervention)
36 items self-report scale: Higher scores suggest greater problems with emotion regulation.
V3 (3 months after the intervention)
Changes from Baseline in Emotion Dysregulation Inventory (EDI)
Time Frame: V2 (within two weeks after the end of the intervention)
Informant-report measure of emotion dysregulation
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Emotion Dysregulation Inventory (EDI)
Time Frame: V3 (3 months after the intervention)
Informant-report measure of emotion dysregulation
V3 (3 months after the intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: V2 (within two weeks after the end of the intervention)
Self-report inventory scored from 0 to 63 (higher score = more severe depressive symptoms)
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: V3 (3 months after the intervention)
Self-report inventory scored from 0 to 63 (higher score = more severe depressive symptoms)
V3 (3 months after the intervention)
Changes from Baseline in State-Trait Anxiety Inventory (STAI)
Time Frame: V2 (within two weeks after the end of the intervention)
40 self-report items on a 4-point Likert scale: higher scores = greater anxiety
V2 (within two weeks after the end of the intervention)
Changes from Baseline in State-Trait Anxiety Inventory (STAI)
Time Frame: V3 (3 months after the intervention)
40 self-report items on a 4-point Likert scale: higher scores = greater anxiety
V3 (3 months after the intervention)
Changes from Baseline in self-report Family Attitude Scale (FAS)
Time Frame: V2 (within two weeks after the end of the intervention)
30-item, Likert-scaled assessment for measuring the emotional climate of families (higher score = more critical family environment)
V2 (within two weeks after the end of the intervention)
Changes from Baseline in self-report Family Attitude Scale (FAS)
Time Frame: V3 (3 months after the intervention)
30-item, Likert-scaled assessment for measuring the emotional climate of families (higher score = more critical family environment)
V3 (3 months after the intervention)
Changes from Baseline in parent-report Family Attitude Scale (FAS)
Time Frame: V2 (within two weeks after the end of the intervention)
30-item, Likert-scaled assessment for measuring the emotional climate of families (higher score = more critical family environment)
V2 (within two weeks after the end of the intervention)
Changes from Baseline in parent-report Family Attitude Scale (FAS)
Time Frame: V3 (3 months after the intervention)
30-item, Likert-scaled assessment for measuring the emotional climate of families (higher score = more critical family environment)
V3 (3 months after the intervention)
Changes from Baseline in Borderline Symptom List (BSL-23)
Time Frame: V2 (within two weeks after the end of the intervention)
Self-rating tool for Borderline Personality Disorder (BPD) symptoms: higher scores = more likely to have BPD and associated challenges
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Borderline Symptom List (BSL-23)
Time Frame: V3 (3 months after the intervention)
Self-rating tool for BPD symptoms: higher scores = more likely to have BPD and associated challenges
V3 (3 months after the intervention)
Changes from Baseline in self-report Strength & Difficulties Questionnaire (SDQ)
Time Frame: V2 (within two weeks after the end of the intervention)
brief emotional and behavioural screening questionnaire assessing 25 attributes, some positive and others negative.
V2 (within two weeks after the end of the intervention)
Changes from Baseline in self-report Strength & Difficulties Questionnaire (SDQ)
Time Frame: V3 (3 months after the intervention)
brief emotional and behavioural screening questionnaire assessing 25 attributes, some positive and others negative.
V3 (3 months after the intervention)
Changes from Baseline in parent-report Strength & Difficulties Questionnaire (SDQ)
Time Frame: V2 (within two weeks after the end of the intervention)
brief emotional and behavioural screening questionnaire assessing 25 attributes, some positive and others negative.
V2 (within two weeks after the end of the intervention)
Changes from Baseline in parent-report Strength & Difficulties Questionnaire (SDQ)
Time Frame: V3 (3 months after the intervention)
brief emotional and behavioural screening questionnaire assessing 25 attributes, some positive and others negative.
V3 (3 months after the intervention)
Changes from Baseline in Cognitive Emotion Regulation Questionnaire (CERQ)
Time Frame: V2 (within two weeks after the end of the intervention)
Self-report measure designed to assess individual differences in cognitive regulation of emotions in response to stressful events. subscale scores can range from 4 to 20 with higher subscale scores indicating greater frequency of use of the specific cognitive strategy.
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Cognitive Emotion Regulation Questionnaire (CERQ)
Time Frame: V3 (3 months after the intervention)
Self-report measure designed to assess individual differences in cognitive regulation of emotions in response to stressful events. subscale scores can range from 4 to 20 with higher subscale scores indicating greater frequency of use of the specific cognitive strategy.
V3 (3 months after the intervention)
Changes from Baseline in Kentucky inventory of mindfulness skills (KIMS)
Time Frame: V2 (within two weeks after the end of the intervention)
self-report measuring Mindfulness on four scales: Observing, Describing, Act With Awareness, and Accept Without Judgment. Higher scores = higher mindfulness
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Kentucky inventory of mindfulness skills (KIMS)
Time Frame: V3 (3 months after the intervention)
self-report measuring Mindfulness on four scales: Observing, Describing, Act With Awareness, and Accept Without Judgment. Higher scores = higher mindfulness
V3 (3 months after the intervention)
Changes from Baseline in Perceived Parental Autonomy Support Scale (P-PASS)
Time Frame: V2 (within two weeks after the end of the intervention)
Measures parental autonomy-support and control of late adolescents and emerging adults. 24 items, assessed on a 7 point Likert scale.
V2 (within two weeks after the end of the intervention)
Changes from Baseline in Perceived Parental Autonomy Support Scale (P-PASS)
Time Frame: V3 (3 months after the intervention)
Measures parental autonomy-support and control of late adolescents and emerging adults. 24 items, assessed on a 7 point Likert scale.
V3 (3 months after the intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Anticipated)

September 6, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

January 11, 2023

First Submitted That Met QC Criteria

February 8, 2023

First Posted (Estimate)

February 20, 2023

Study Record Updates

Last Update Posted (Estimate)

February 20, 2023

Last Update Submitted That Met QC Criteria

February 8, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-01883

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Emotion regulation group

3
Subscribe